Engineering Dual Active Sites and Defect Structure in Nanozymes to Reprogram Jawbone Microenvironment for Osteoradionecrosis Therapy DOI Creative Commons

Zheng Cheng,

Yuchen Wang,

Haobo Lin

и другие.

Advanced Science, Год журнала: 2024, Номер unknown

Опубликована: Дек. 17, 2024

Four to eight percent of patients with head and neck cancer will develop osteoradionecrosis the jaw (ORNJ) after radiotherapy. Various radiation-induced tissue injuries are associated reactive oxygen nitrogen species (RONS) overproduction. Herein, Fe doping is used in VO

Язык: Английский

Research progress on the synthesis, performance regulation, and applications of Prussian blue nanozymes DOI
Yiyang Wang, Lei Gao, Yue Cao

и другие.

International Journal of Biological Macromolecules, Год журнала: 2025, Номер 295, С. 139535 - 139535

Опубликована: Янв. 5, 2025

Язык: Английский

Процитировано

0
Intra-articular injection of MOF-based nanomaterials for the treatment of osteoarthritis by modulating the bone microenvironment DOI Creative Commons
Bing Tan, Yuhao Zheng, Jie Hao

и другие.

Advanced Composites and Hybrid Materials, Год журнала: 2025, Номер 8(1)

Опубликована: Янв. 17, 2025

Язык: Английский

Процитировано

0
Regulator of oxidative balance: Research progress of nanozymes in ROS-related diseases DOI
Xiang Wang, Zidong Wang, Siyuan Hu

и другие.

Materials Today Chemistry, Год журнала: 2025, Номер 44, С. 102540 - 102540

Опубликована: Янв. 22, 2025

Язык: Английский

Процитировано

0
Investigation into recent advanced strategies of reactive oxygen species-mediated therapy based on Prussian blue: Conceptualization and prospect DOI
Hee Young Kwon, Yuna Jung, Hojeong Jeon

и другие.

Bioactive Materials, Год журнала: 2025, Номер 48, С. 71 - 99

Опубликована: Фев. 13, 2025

Язык: Английский

Процитировано

0
Intelligent Nanomaterials Design for Osteoarthritis Managements DOI Open Access
Zhihao Chen, Xuan Zheng, Zhengzhi Mu

и другие.

Small Methods, Год журнала: 2025, Номер unknown

Опубликована: Март 30, 2025

Osteoarthritis (OA) is the most prevalent degenerative joint disorder, characterized by progressive degradation, pain, and diminished mobility, all of which collectively impair patients' quality life escalate healthcare expenditures. Current treatment options are often inadequate due to limited efficacy, adverse side effects, temporary symptom relief, underscoring urgent need for more effective therapeutic strategies. Recent advancements in nanomaterials nanomedicines offer promising solutions improving drug bioavailability, reducing effects providing targeted benefits. This review critically examines pathogenesis OA, highlights limitations existing treatments, explores latest innovations intelligent design OA therapy, with an emphasis on their engineered properties, mechanisms, translational potential clinical application. By compiling recent findings, this work aims inspire further exploration innovation nanomedicine, ultimately advancing development personalized therapies.

Язык: Английский

Процитировано

0
Engineering Dual Active Sites and Defect Structure in Nanozymes to Reprogram Jawbone Microenvironment for Osteoradionecrosis Therapy DOI Creative Commons

Zheng Cheng,

Yuchen Wang,

Haobo Lin

и другие.

Advanced Science, Год журнала: 2024, Номер unknown

Опубликована: Дек. 17, 2024

Four to eight percent of patients with head and neck cancer will develop osteoradionecrosis the jaw (ORNJ) after radiotherapy. Various radiation-induced tissue injuries are associated reactive oxygen nitrogen species (RONS) overproduction. Herein, Fe doping is used in VO

Язык: Английский

Процитировано

1